$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The formation of the 3' end is a critical step in mRNA maturation that comprises the cleavage of the pre-mRNA downstream of a PAS followed by the addition of ~250 untemplated adenines, which make up the poly(A) tail1,2. The poly(A) binding protein (PABP) binds to the poly(A) tail, and this protects the mRNA transcript from degradation, and facilitates translation1.
Current estimates suggest that 70% of human genes have multiple PASs, and thus undergo alternative polyadenylation, resulting in multiple 3' ends3. Thus, it is important to identify where the poly(A) tail attaches to the rest of the 3' UTR, as well as identify the PAS used by any given transcript. The advent of next-generation sequencing has resulted in the simultaneous identification of the 3' UTRs and the PASs of thousands of genes. This increase in sequencing capability has required the development of bioinformatic algorithms to analyze data involving alternative polyadenylation of the 3' end. For the de novo detection or validation of the PAS and hence mapping of the 3' end of individual genes from large scale sequencing data, 3' RACE remains the method of choice4,5. The sequences included in cDNA products of 3' RACE normally include only a portion of the 3' UTR that contains the poly(A) tail, the cleavage site, the PAS, and the sequences upstream of the PAS. Unlike PCR, which requires the design and use of gene specific forward and reverse primers, 3' RACE only requires two gene specific nested forward primers. Hence, PCR requires a more detailed knowledge of the nucleotide sequence of a large region of the gene being amplified4,6. Since 3' RACE uses the same reverse primer that targets the poly(A) tail for all polyadenylated RNA transcripts, only the forward primers need to be gene specific, thus, only requiring knowledge of a significantly smaller region of the mRNA. This enables the amplification of regions whose sequences are not fully characterized4,7. This has allowed 3' RACE to be used not only to determine the 3' end of a gene, but to also determine and characterize large regions upstream of the PAS that form a significant portion of the 3' UTR. By combining 5' RACE with the modified 3' RACE that includes larger portions of the 3' UTR and flanking regions, it is possible to fully sequence or clone an entire mRNA transcript from the 5' end to its 3' end8.
An example of this application of modified 3' RACE is the recent identification of a novel CCND1-MRCK fusion gene transcript from Mantle Cell Lymphoma cell lines and cancer patients. The 3' UTR consisted of sequences from both the CCND1 and MRCK genes and was recalcitrant to miRNA regulation9. The two nested CCND1 specific forward primers were complementary to the region immediately adjacent and downstream of the CCND1 stop codon. Although whole transcriptome sequencing together with specific bioinformatic tools can be used to detect gene fusions within the 3' UTR10, many labs may lack the financial resources or bioinformatic expertise to make use of this technology. Hence, 3' RACE is an alternative for de novo identification and validation of novel fusion genes involving the 3' UTR. Considering the drastic increase in the number of reported fusion genes as well as read through transcripts, 3' RACE has become a powerful tool in characterizing gene sequences11,12. In addition, recent studies have shown that different sequences within the 3' UTR as well as the length of the 3' UTR can affect mRNA transcript stability, localization, translatability, and function13. Due in part to an increased interest in mapping the transcriptome, there has been an increase in the number of different DNA polymerases being developed for use in the lab. It is important to determine what types of modifications can be made to the 3' RACE protocol in order to utilize the available repertoire of DNA polymerases.
This work reports adapting 3' RACE to map the entire 3' UTR, the PAS, and the 3' end cleavage site of the ANKHD1 transcript by using nested primers within the ANKHD1 section of the transcript and two different DNA polymerases.